HB 867 Call Your Representative

January 25, 2022

House Chairman and physician Mark Newton introduced HB 867, which requires PBMs to calculate patient cost sharing for prescription drugs based on true costs to plans, by taking into account rebates PBMs receive from pharmaceutical manufacturers. PBMs are in opposition to this legislation and trying to point the finger at independent pharmacies for rising drug costs at the counter.

The bill is scheduled for a hearing tomorrow in Chairman Newton’s Special Committee on Access to Quality Healthcare. Below are members of that Committee. Please reach out to committee members prior to 2:00 pm tomorrow and let them know:

You are in support in support of HB 867, as it will reduce prices for Georgia patients at the counter by requiring PBMs to factor in rebates received when calculating a patient’s cost share;
If PBMs are negotiating rebates, patients should receive the benefit of those discounts at the counter and should not pay cost shares based in inflated pricing at the drug counter; and
Community pharmacies do not benefit in any way from this legislation financially, but you are in support because this legislation increases drug pricing transparency and reduces drug costs for patients at the counter.

Rectangular buttons

GPhA Family

The GPhA Family

HB 867 Call Your Representative